Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
Chibuzo Sampson, Qiuping Wang, Wuxiyar Otkur, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 23
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer
Aastha Kaushik, Somya Parashar, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102279-102279
Closed Access | Times Cited: 6
UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
Renyu Zhang, C. Li, Shuai Zhang, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 771-792
Open Access | Times Cited: 5
RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells
Hangyu Xu, Qing Yin, Linna Fan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Feedback loop centered on MAF1 reduces blood–brain barrier damage in sepsis-associated encephalopathy
Xue‐biao Wei, Wenqiang Jiang, Zhonghua Wang, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
Sally E. Claridge, Shalini Nath, Andrew Baum, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Proteomic Characterization of NEDD4 Unveils Its Potential Novel Downstream Effectors in Gastric Cancer
Jisoo Han, Yoonhee Shin, Eunjung Kim, et al.
Journal of Proteome Research (2025)
Closed Access
Proteasomal Dysfunction in Cancer: Mechanistic Pathways and Targeted Therapies
Pranit Hemant Bagde, Meenakshi Kandpal, Annu Rani, et al.
Journal of Cellular Biochemistry (2025) Vol. 126, Iss. 1
Closed Access
Portrait of WWP1: the current state in human cancer
Jiaming Lei, Jun Chen, Wenwen Yu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Enhanced Expression of TRIM46 in Ovarian Cancer Cells Induced by Tumor-Associated Macrophages Promotes Invasion via the Wnt/β-Catenin Pathway
Yiyue Wang, Minjun Choi, Jin Hyung Kim, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 214-214
Open Access
Implication of protein post translational modifications in gastric cancer
Houji Song, Mingze Zhang, Chengwang Guo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins
Ishaar P. Ganesan, Hiroaki Kiyokawa
Cancers (2025) Vol. 17, Iss. 4, pp. 626-626
Open Access
Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination
Zhenheng Wu, You Peng, Wen Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Histone modification inhibitors: An emerging frontier in thyroid Cancer therapy
Qi Wang, Shu Sun, Guojun Sun, et al.
Cellular Signalling (2025), pp. 111703-111703
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy
Rajeshwari Meli, Osman Aksoy, Sonia Vallet, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
Target protein degradation by protacs: A budding cancer treatment strategy
Diksha Choudhary, Amritpal Kaur, Pargat Singh, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108525-108525
Closed Access | Times Cited: 12
miR-34a-5p/MARCHF8/ADAM10 axis in the regulation of vascular endothelial cell dysfunction and senescence
Zonghao Qian, Yuzhen Huang, Ni Yang, et al.
Mechanisms of Ageing and Development (2025) Vol. 225, pp. 112060-112060
Closed Access
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
Jonahunnatha Nesson George William, Ruby Dhar, Rohit Gundamaraju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Advances of E3 ligases in lung cancer
Jingwen Yu, Yiqi Zhao, Yue Xie
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101740-101740
Open Access | Times Cited: 3
IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells
Adriana Rosa Gambardella, Caterina Antonucci, Cristiana Zanetti, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1
Xianfu Wei, Jinyan Feng, Long Chen, et al.
Cancer Letters (2024), pp. 217194-217194
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top